Baker Avenue Asset Management, LP

Position in BMY — Bristol Myers Squibb Co

CIK 1432529 SAN FRANCISCO, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,006,909

-$376,699 QoQ

Shares Held

17,475

-23.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,153

of 2,506 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 43% Shared 0% None 57%

Healthcare · as of Jun 30, 2026

Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. BMY ranks #7 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	26,531	$31,822,079
2	ABBV	AbbVie Inc.	85,535	$21,524,027
3	JNJ	Johnson & Johnson	43,298	$10,996,393
4	GILD	Gilead Sciences, Inc.	59,347	$7,497,899
5	MRK	Merck & Co., Inc.	51,784	$6,654,244
6	AMGN	Amgen Inc	15,621	$5,656,676
7	BMY	Bristol Myers Squibb Co This page	17,475	$1,006,909
8	PFE	Pfizer Inc	40,733	$980,850

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,006,909	17,475	-23.4%	Shares	Sole	2026-07-28
2026-03-31	$1,383,608	22,813	+156.8%	Shares	Sole	2026-05-12
2025-12-31	$479,149	8,883	+1.7%	Shares	Sole	2026-02-10
2025-09-30	$393,993	8,736	+83.8%	Shares	Sole	2025-10-31
2025-06-30	$219,970	4,752	+35.0%	Shares	Sole	2025-08-13
2025-03-31	$214,684	3,520	-10.9%	Shares	Sole	2025-05-08
2024-12-31	$223,525	3,952	+174.3%	Shares	Sole	2025-02-14
2023-09-30	$83,635	1,441	-10.8%	Shares	Sole	2023-11-15
2023-06-30	$103,279	1,615	+42.5%	Shares	Sole	2023-08-14
2023-03-31	$78,528	1,133	+18.6%	Shares	Sole	2023-05-16
2022-12-31	$68,712	955	-91.6%	Shares	Sole	2023-02-14
2022-06-30	$876,106	11,378	+59.3%	Shares	Sole	2022-08-03
2022-03-31	$521,653	7,143	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.